Last updated on November 2017

Dementia Research Study (Lewy Bodies)

Brief description of study

Dementia Research Study (Lewy Bodies)

Detailed Study Description

A Study Evaluating RVT-101 in Subjects with Dementia with Lewy Bodies:

Study Design:

  • A double-blind, randomized, placebo-controlled study in 240 individuals with a diagnosis of dementia with Lewy bodies
  • Total participation in the study will be about 32 weeks, including the screening period
  • Stable background therapy will be allowed
  • Following completion of this study, individuals will be able to participate in an extension study where all participants will receive RVT-101

About RVT-101

  • RVT-101 works by blocking the 5HT6 receptor in the brain and raising levels of acetylcholine, a vital chemical in the brain that helps with cognition
  • RVT-101 has been studied in 13 clinical trials and administered in more than 1,250 people. It is currently in a global Phase 3 study in Alzheimer’s disease

The Memory Health Center at Summit Research Network has been researching memory loss and brain health since 1976. If you qualify to participate, you will receive research related medication and care, office visits, and travel reimbursement at no cost.

For more information about memory loss and this research study, please call us at 503-228-2273 or visit our website at

Clinical Study Identifier: TX7834

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )